Citigroup’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-518,600
Closed -$1.98M 5815
2024
Q4
$1.98M Sell
518,600
-131,300
-20% -$708K ﹤0.01% 2833
2024
Q3
$4.66M Buy
+649,900
New +$4.62M ﹤0.01% 1911
2024
Q2
Sell
-257,500
Closed -$2.58M 5711
2024
Q1
$2.58M Sell
257,500
-136,200
-35% -$1.19M ﹤0.01% 2233
2023
Q4
$2.76M Sell
393,700
-1,218,300
-76% -$8.1M ﹤0.01% 1987
2023
Q3
$12.8M Buy
1,612,000
+96,100
+6% +$606K 0.01% 990
2023
Q2
$8.4M Buy
+1,515,900
New +$8.31M 0.01% 1213
2023
Q1
Sell
-179,400
Closed -$1.25M 5730
2022
Q4
$1.25M Buy
+179,400
New +$1.85M ﹤0.01% 2419

Other funds holding MSOS

Citigroup's MSOS Position: Q2 2026 in Review

Citigroup reduced its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 5.8% in Q2 2026, selling an estimated $241K and leaving 837,309 shares worth $4.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2288.

Citigroup first reported a position in MSOS in Q1 2021 and has held it in 21 quarters since. The position peaked at $10.4M in Q1 2024. 169 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • Citigroup held 837,309 shares of AdvisorShares Pure US Cannabis ETF worth $4.25M as of Q2 2026.
  • Citigroup sold 51,453 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $241K.
  • AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2288 holding.
  • Citigroup first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2021 and has held it in 21 quarters since.
  • Citigroup's AdvisorShares Pure US Cannabis ETF position peaked at $10.4M in Q1 2024.
  • 169 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.